Compare AdaptHealth Corp (AHCO) vs Vanguard Mega Cap Growth ETF (MGK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Vanguard Mega Cap Growth ETF — how do they compare? AdaptHealth Corp trades at $5.8 (market cap $753.09M), while Vanguard Mega Cap Growth ETF trades at $90.18. The key difference: Vanguard Mega Cap Growth ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | MGK | |
|---|---|---|
Market Cap | $753.09M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $13.38 | $92.06 |
52-Week Low | $5.22 | $70.70 |
Enterprise Value | $2.77B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.77, up 10.54% today but remains under significant pressure following recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal revenue growth but negative profitability margins. Recent news highlights multiple securities fraud investigations and a strategic shift through the sale of its diabetes unit to focus on sleep and respiratory care.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting substantial upside, immediate risks are elevated. The company faces execution challenges with fixed-price contracts, ongoing legal scrutiny, and consecutive earnings misses. Investors must weigh the potential recovery against substantial operational and legal headwinds.
MGK trades at $90.21, down 0.46% on the day, with a bullish technical signal supported by moving averages. The ETF focuses on mega-cap growth stocks with heavy technology concentration and a low 0.05% expense ratio. Recent news highlights institutional buying activity and strong five-year performance compared to peers.
Outlook remains positive given MGK's track record of outperforming the S&P 500, though high RSI readings suggest potential near-term consolidation. Risks include concentration in tech stocks and market volatility, but the ETF's low-cost structure and exposure to market leaders provide long-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Vanguard Mega Cap Growth ETF
MGK is an ETF that seeks to track the performance of the CRSP US Mega Cap Growth Index. It provides a low-cost, diversified exposure to the largest growth companies in the U.S. stock market. The fund is composed of mega-cap stocks that exhibit key growth factors, including high expected long-term earnings growth, high historical sales and earnings growth, and high return on assets. MGK is typically used by investors seeking long-term capital appreciation from market-leading firms.
Read more on MGK →
